Uni-Bio Science Group: 2021 Interim Results
- Written by Media Outreach
Successful Turnaround to Profit-making with Record-High Turnover
Expanding R&D Activity in Nanobody Drug to Diversify Product Portfolio
HONG KONG SAR - EQS Newswire - 27 August 2021 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred...














